Cargando…

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea

The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Sook-In, Shin, Jong Hee, Choi, Hyun-Jung, Ju, Min-Young, Kim, Soo-Hyun, Lee, Wee Gyo, Park, Yeon-Joon, Lee, Kyungwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2012
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486937/ https://www.ncbi.nlm.nih.gov/pubmed/23130342 http://dx.doi.org/10.3343/alm.2012.32.6.426

Ejemplares similares

In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
por: Jang, Min Joong, et al.
Publicado: (2013)

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022)

Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
por: Won, Eun Jeong, et al.
Publicado: (2021)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine
por: Storm, Line, et al.
Publicado: (2014)

Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea
por: Lee, Jin-Sol, et al.
Publicado: (2007)

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage
por: Won, Eun Jeong, et al.
Publicado: (2015)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

Profile susceptibility to fluconazole and voriconazole antifungals by species of Candida albicans isolated from urine culture
por: Wiebusch, Laura, et al.
Publicado: (2014)

Mutants with heteroresistance to amphotericin B and fluconazole in Candida
por: Claudino, A.L.R., et al.
Publicado: (2009)

Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes
por: Byun, Seung A., et al.
Publicado: (2018)

P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans
por: Aslani, Narges
Publicado: (2022)

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
por: Dromer, Françoise, et al.
Publicado: (2008)

Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
por: Lo, Wei-Hsuan, et al.
Publicado: (2020)

Molecular and Clinical Features of Fluconazole Non-susceptible Candida albicans Bloodstream Isolates Recovered in Korean Multicenter Surveillance Studies
por: Choi, Min Ji, et al.
Publicado: (2023)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine
por: Al-Sweih, Noura, et al.
Publicado: (2014)

P092 Otilonium bromide is a potent antifungal agent against fluconazole- and flucytosine-resistant Cryptococcus neoformans strains
por: Zhen, Cheng, et al.
Publicado: (2022)

Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
por: Choi, Yong Jun, et al.
Publicado: (2018)

Flucytosine and Amphotericin B Coadministration Induces Dose-Related Renal Injury
por: Folk, Alexandra, et al.
Publicado: (2017)

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan
por: Yang, Yun-Liang, et al.
Publicado: (2005)

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
por: Xu, Lijun, et al.
Publicado: (2019)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2022)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Evaluation of Hepatotoxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections
por: Folk, Alexandra, et al.
Publicado: (2016)

Evaluation of fluconazole, itraconazole, and voriconazole activity on Candida albicans: A case control study
por: Partha, Agung Dewi Sekar Langit, et al.
Publicado: (2022)

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic
por: Trevijano-Contador, Nuria, et al.
Publicado: (2022)

829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin
por: McHale, Thomas, et al.
Publicado: (2023)

Clonality of Fluconazole-Nonsusceptible Candida tropicalis in Bloodstream Infections, Taiwan, 2011–2017
por: Chen, Pao-Yu, et al.
Publicado: (2019)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
por: Udawatte, Nadeeka S., et al.
Publicado: (2020)

Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
por: Shiri, Tinevimbo, et al.
Publicado: (2020)

Limitation of the Benefit of Amphotericin-Flucytosine Combination Therapy in Patients With Lower Conscious Level: An Ecological Fallacy?
por: Wolbers, Marcel, et al.
Publicado: (2015)

An Elderly Patient with Pulmonary Cryptococcosis with Mediastinal Lymphadenopathy Who Was Successfully Treated with Amphotericin B and Flucytosine
por: Fujimoto, Shusaku, et al.
Publicado: (2020)

Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model
por: El-Azizi, Mohamed, et al.
Publicado: (2015)

376. Predictive Model for Fluconazole Resistance in Patient With Candida Bloodstream Infection
por: Aljorayid, Abdullah, et al.
Publicado: (2018)

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
por: Morfín-Otero, Rayo, et al.
Publicado: (2018)

Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Suchodolski, Jakub, et al.
Publicado: (2021)

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates
por: de Aquino Lemos, Janine, et al.
Publicado: (2009)

Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates
por: Denardi, Laura Bedin, et al.
Publicado: (2015)

Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
por: Alshaya, Omar A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ud9m8116ju64juk4k627e50al8